367 related articles for article (PubMed ID: 15476992)
1. A prospective study of the use of alternative therapies by men with localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Patient Educ Couns; 2004 Oct; 55(1):70-7. PubMed ID: 15476992
[TBL] [Abstract][Full Text] [Related]
2. Prospective study of men's psychological and decision-related adjustment after treatment for localized prostate cancer.
Steginga SK; Occhipinti S; Gardiner RA; Yaxley J; Heathcote P
Urology; 2004 Apr; 63(4):751-6. PubMed ID: 15072894
[TBL] [Abstract][Full Text] [Related]
3. Clinical, demographic and psychosocial correlates of complementary and alternative medicine use by men diagnosed with localized prostate cancer.
Diefenbach MA; Hamrick N; Uzzo R; Pollack A; Horwitz E; Greenberg R; Engstrom PF
J Urol; 2003 Jul; 170(1):166-9. PubMed ID: 12796672
[TBL] [Abstract][Full Text] [Related]
4. Men with prostate cancer: making decisions about complementary/alternative medicine.
Boon H; Brown JB; Gavin A; Westlake K
Med Decis Making; 2003; 23(6):471-9. PubMed ID: 14672107
[TBL] [Abstract][Full Text] [Related]
5. A population-based survey of complementary and alternative medicine use in men recently diagnosed with prostate cancer.
Eng J; Ramsum D; Verhoef M; Guns E; Davison J; Gallagher R
Integr Cancer Ther; 2003 Sep; 2(3):212-6. PubMed ID: 15035882
[TBL] [Abstract][Full Text] [Related]
6. Sex differences in motives for use of complementary and alternative medicine among cancer patients.
Hedderson MM; Patterson RE; Neuhouser ML; Schwartz SM; Bowen DJ; Standish LJ; Marshall LM
Altern Ther Health Med; 2004; 10(5):58-64. PubMed ID: 15478787
[TBL] [Abstract][Full Text] [Related]
7. The application of the heuristic-systematic processing model to treatment decision making about prostate cancer.
Steginga SK; Occhipinti S
Med Decis Making; 2004; 24(6):573-83. PubMed ID: 15534339
[TBL] [Abstract][Full Text] [Related]
8. Evaluating peer support for prostate cancer: the Prostate Cancer Peer Support Inventory.
Steginga SK; Pinnock C; Gardner M; Gardiner RA; Dunn J
BJU Int; 2005 Jan; 95(1):46-50. PubMed ID: 15663527
[TBL] [Abstract][Full Text] [Related]
9. Provision of individualized information to men and their partners to facilitate treatment decision making in prostate cancer.
Davison BJ; Goldenberg SL; Gleave ME; Degner LF
Oncol Nurs Forum; 2003; 30(1):107-14. PubMed ID: 12515988
[TBL] [Abstract][Full Text] [Related]
10. Changing patterns of CAM use among prostate cancer patients two years after diagnosis: reasons for maintenance or discontinuation.
Porter M; Kolva E; Ahl R; Diefenbach MA
Complement Ther Med; 2008 Dec; 16(6):318-24. PubMed ID: 19028331
[TBL] [Abstract][Full Text] [Related]
11. Informed decision making and prostate specific antigen (PSA) testing for prostate cancer: a randomised controlled trial exploring the impact of a brief patient decision aid on men's knowledge, attitudes and intention to be tested.
Watson E; Hewitson P; Brett J; Bukach C; Evans R; Edwards A; Elwyn G; Cargill A; Austoker J
Patient Educ Couns; 2006 Nov; 63(3):367-79. PubMed ID: 16875796
[TBL] [Abstract][Full Text] [Related]
12. Understanding the motivation for conventional and complementary/alternative medicine use among men with prostate cancer.
Singh H; Maskarinec G; Shumay DM
Integr Cancer Ther; 2005 Jun; 4(2):187-94. PubMed ID: 15911931
[TBL] [Abstract][Full Text] [Related]
13. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
Denberg TD; Melhado TV; Steiner JF
Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
[TBL] [Abstract][Full Text] [Related]
14. Use of complementary and alternative medicine in men with family history of prostate cancer: a pilot study.
Beebe-Dimmer JL; Wood DP; Gruber SB; Douglas JA; Bonner JD; Mohai C; Zuhlke KA; Shepherd C; Cooney KA
Urology; 2004 Feb; 63(2):282-7. PubMed ID: 14972472
[TBL] [Abstract][Full Text] [Related]
15. Psychological distress in Japanese men with localized prostate cancer.
Namiki S; Saito S; Tochigi T; Numata I; Ioritani N; Arai Y
Int J Urol; 2007 Oct; 14(10):924-9. PubMed ID: 17880290
[TBL] [Abstract][Full Text] [Related]
16. Do anxiety and distress increase during active surveillance for low risk prostate cancer?
van den Bergh RC; Essink-Bot ML; Roobol MJ; Schröder FH; Bangma CH; Steyerberg EW
J Urol; 2010 May; 183(5):1786-91. PubMed ID: 20299064
[TBL] [Abstract][Full Text] [Related]
17. Taiwanese adult cancer patients' reports of using complementary therapies.
Lu JH; Tsay SL; Sung SC
Cancer Nurs; 2010; 33(4):320-6. PubMed ID: 20467307
[TBL] [Abstract][Full Text] [Related]
18. Information needs of men regarding prostate cancer screening and the effect of a brief decision aid.
Sheridan SL; Felix K; Pignone MP; Lewis CL
Patient Educ Couns; 2004 Sep; 54(3):345-51. PubMed ID: 15324986
[TBL] [Abstract][Full Text] [Related]
19. Evidence-based patient choice: a prostate cancer decision aid in plain language.
Holmes-Rovner M; Stableford S; Fagerlin A; Wei JT; Dunn RL; Ohene-Frempong J; Kelly-Blake K; Rovner DR
BMC Med Inform Decis Mak; 2005 Jun; 5():16. PubMed ID: 15963238
[TBL] [Abstract][Full Text] [Related]
20. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer.
Oliffe JL; Davison BJ; Pickles T; Mróz L
Qual Health Res; 2009 Apr; 19(4):432-43. PubMed ID: 19229061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
